Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia

Email: 15195998961@163.com

Education：

The University of Melbourne, WEHI, Personalised Oncology                                        Melbourne, Australia

PhD student                                                                                     2018.09-Present

Nanjing University, Department of Pharmacology                                                      Nanjing, China

Master of Science in Pharmacology                                                                  2015.09- 2018.06

Nanjing University, School of life Sciences                                                             Nanjing, China

Bachelor of Science in Biology                                                                      2011.09- 2015.06

Publication：

Fenli Shao^*, Tao Tan^*, Yang Tan, Yang Sun, Xingxin Wu, Qiang Xu: Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88. Biochemical pharmacology 06/2016; DOI:10.1016/j.bcp.2016.06.001 (^* Co-first author)

Xingxin Wu, Xudong Wu, Yuxiang Ma, Fenli Shao, Yang Tan, Tao Tan, Liyun Gu, Yang Zhou, Beicheng Sun, Yang Sun, Xuefeng Wu, Qiang Xu: CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nature Communications 11/2016; 7:13498., DOI:10.1038/ncomms13498

Yang Tan, Xingxin Wu, Jing Sun, Wenjie Guo, Fangyuan Gong, Fenli Shao, Tao Tan, Yi Cao, Bingfeng Zheng, Yanhong Gu, Yang Sun, Qiang Xu: A fumigaclavine C isostere alleviates Th1-mediated experimental colitis via competing with IFN-γ for binding to IFN-γ receptor 1. Biochemical pharmacology 10/2016; DOI:10.1016/j.bcp.2016.10.004

Xiao Han^*, Ying Wang^*, Jing Sun^*, Tao Tan^*, Xiaomin Cai, Peinan Lin, Yang Tan, Bingfeng Zheng, Biao Wang, Jiawei Wang, Lingyan Xu, Qiang Xu, Xingxin Wu, Yanhong Gu. Role of CXCR3 signaling in response to anti-PD-1 therapy. EBioMedicine 48, 169-177, doi:10.1016/j.ebiom.2019.08.067 (2019). (^* Co-first author)